| For: | Al-Busafi SA, Alwassief A, Madian A, Atalla H, Alboraie M, Elbahrawy A, Eslam M. Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies. World J Hepatol 2025; 17(8): 108730 [PMID: 40901606 DOI: 10.4254/wjh.v17.i8.108730] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i8/108730.htm |
| Number | Citing Articles |
| 1 |
Jhommara Bautista, Andrés López-Cortés. The hallmarks of host-microbiome decoupling. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1801100
|
| 2 |
Vanishri Ganakumar, Abhinay Mahaling, Manjunath Goroshi, Vikrant Ghatnatti. Psychosocial aspects and mental health burden of pediatric MASLD. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1916057
|
| 3 |
Poonam Sahu, Trilochan Satapathy. The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Microbiome Interactions and Therapeutic Targets. Probiotics and Antimicrobial Proteins 2026; doi: 10.1007/s12602-026-11050-6
|
| 4 |
Yitian Du, Manli Wu, Haiqi Wu, Ye Wu, Cantu Fang, Luzhen Li, Huatang Zhang, Yao Wang. Heatwave exposure and gastrointestinal and liver diseases: complementary evidence from a population-based study and animal experiments. Frontiers in Physiology 2026; 17 doi: 10.3389/fphys.2026.1883010
|
| 5 |
春漫 薛. Mechanisms, Epidemiology and Diagnostic Strategies of Metabolic Dysfunction-Associated Fatty Liver Disease. Journal of Clinical Personalized Medicine 2026; 5(02) doi: 10.12677/jcpm.2026.52138
|
| 6 |
Mengran Qi, Feini Qin, Ruoxuan Wang, Yanni Zhang, Xuanfeng Yue. Ethyl caffeate alleviates NAFLD by modulating JNK/IRS-1/AKT signaling and the gut microbiota. Food & Function 2026; doi: 10.1039/D6FO03689A
|
| 7 |
Rajasekhar Komarla Kumarachari, Soundarya Kasi, Hari Veluru, A. Chandramouli, Sundari Krishnamoorthy, M. Jayaseelan. Smart Microbiomes for Personalized Medicine. Advances in Computational Intelligence and Robotics 2026; doi: 10.4018/979-8-3373-8172-5.ch001
|
| 8 |
Said A. Al-Busafi, Mohammed Eslam. The AMAGE guidelines: Metabolic dysfunction-associated fatty liver disease through a regional lens. Annals of Hepatology 2026; 31(1) doi: 10.1016/j.aohep.2026.102205
|
| 9 |
Shi Qiu, Shifa Qiang, Zhibo Wang, Lihua Yang, Sifan Guo, Jiahan Zeng, Ying Cai, Zhicheng Lai, Dandan Xie, Li Che, Aihua Zhang. Babaodan ameliorates metabolic dysfunction-associated steatotic liver disease with co-modulation of FXR, NF-κB, and SLC22A7 in bile acid metabolism. Journal of Ethnopharmacology 2027; 372 doi: 10.1016/j.jep.2026.122201
|
| 10 |
Wu Bao, Gaopeng Li, Yuan Ding, Yuhao Wang. Harnessing the gut microbiome for MASLD management: opportunities and challenges. Science Bulletin 2026; 71(15) doi: 10.1016/j.scib.2026.05.017
|